• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-15b-5p在肝细胞癌中的致癌价值及生物信息学研究

Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.

作者信息

Pan Wen-Ya, Zeng Jiang-Hui, Wen Dong-Yue, Wang Jie-Yu, Wang Peng-Peng, Chen Gang, Feng Zhen-Bo

机构信息

Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

Department of Ultrasonography, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.

出版信息

Oncol Lett. 2019 Feb;17(2):1695-1713. doi: 10.3892/ol.2018.9748. Epub 2018 Nov 22.

DOI:10.3892/ol.2018.9748
PMID:30675229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6341845/
Abstract

miR-15b-5p has frequently been reported to function as a biomarker in some malignancies; however, the function of miR-15b-5p in hepatocellular carcinoma (HCC) and its molecular mechanism are still not well understood. The present study was designed to confirm the clinical value of miR-15b-5p and further explore its underlying molecular mechanism. A comprehensive investigation of the clinical value of miR-15b-5p in HCC was investigated by data mining The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets as well as literature. In addition, intersected target genes of miR-15b-5p were predicted using the miRWalk database and differentially expressed genes of HCC from TCGA. Furthermore, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were carried out. Then, a protein-protein interaction network (PPI) was constructed to reveal the interactions between some hub target genes of miR-15b-5p. The miR-15b-5p expression level in HCC was predominantly overexpressed compared with non-HCC tissues samples (SMD=0.618, 95% CI: 0.207, 1.029; P<0.0001) based on 991 HCC and 456 adjacent non-HCC tissue samples. The pooled summary receiver operator characteristic (SROC) of miR-15b-5p was 0.81 (Q*=0.74), and the pooled sensitivity and specificity of miR-15b-5p in HCC were 72% (95% CI: 69-75%) and 68% (95% CI: 65-72%), respectively. Bioinformatically, 225 overlapping genes were selected as prospective target genes of miR-15b-5p in HCC, and profoundly enriched GO terms and KEGG pathway investigation in silico demonstrated that the target genes were associated with prostate cancer, proximal tubule bicarbonate reclamation, heart trabecula formation, extracellular space, and interleukin-1 receptor activity. Five genes (ACACB, RIPK4, MAP2K1, TLR4 and IGF1) were defined as hub genes from the PPI network. The high expression of miR-15b-5p could play an essential part in hepatocarcinogenesis through diverse regulation approaches.

摘要

miR-15b-5p常被报道在某些恶性肿瘤中作为生物标志物发挥作用;然而,miR-15b-5p在肝细胞癌(HCC)中的功能及其分子机制仍未完全明确。本研究旨在确认miR-15b-5p的临床价值,并进一步探究其潜在的分子机制。通过挖掘癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)数据集以及相关文献,对miR-15b-5p在HCC中的临床价值进行了全面调查。此外,利用miRWalk数据库和来自TCGA的HCC差异表达基因预测了miR-15b-5p的交集靶基因。进一步进行了基因本体论(GO)和京都基因与基因组百科全书(KEGG)通路分析。然后,构建了蛋白质-蛋白质相互作用网络(PPI)以揭示miR-15b-5p的一些核心靶基因之间的相互作用。基于991例HCC组织样本和456例相邻非HCC组织样本,HCC中miR-15b-5p的表达水平与非HCC组织样本相比主要呈过表达(标准化均数差=0.618,95%置信区间:0.207,1.029;P<0.0001)。miR-15b-5p的汇总综合受试者工作特征曲线(SROC)为0.81(Q*=0.74),miR-15b-5p在HCC中的汇总敏感性和特异性分别为72%(95%置信区间:69-75%)和68%(95%置信区间:65-72%)。从生物信息学角度来看,225个重叠基因被选为HCC中miR-15b-5p的潜在靶基因,计算机模拟中深度富集的GO术语和KEGG通路研究表明,这些靶基因与前列腺癌肾小管近端碳酸氢盐重吸收、心脏小梁形成、细胞外空间和白细胞介素-1受体活性相关。五个基因(ACACB、RIPK4、MAP2K1、TLR4和IGF1)被定义为PPI网络中的核心基因。miR-15b-5p的高表达可能通过多种调控途径在肝癌发生过程中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/d5fb6a3e04ef/ol-17-02-1695-g18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/a5d854ae416e/ol-17-02-1695-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/33dae93223c1/ol-17-02-1695-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/45f78f0bc593/ol-17-02-1695-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/1ca836010437/ol-17-02-1695-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/6de3312d9fbb/ol-17-02-1695-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/b9c1702169e2/ol-17-02-1695-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/16fe54b08042/ol-17-02-1695-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/0538342a16b8/ol-17-02-1695-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/112c274f832e/ol-17-02-1695-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/061701fdbd28/ol-17-02-1695-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/59fccd9b4400/ol-17-02-1695-g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/ec439a0d33cb/ol-17-02-1695-g11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/8c317c7b5830/ol-17-02-1695-g12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/5a49a924c363/ol-17-02-1695-g13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/d74284a6c1ec/ol-17-02-1695-g14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/586854b775aa/ol-17-02-1695-g15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/4cbf665527d9/ol-17-02-1695-g16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/6befa44d5def/ol-17-02-1695-g17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/d5fb6a3e04ef/ol-17-02-1695-g18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/a5d854ae416e/ol-17-02-1695-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/33dae93223c1/ol-17-02-1695-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/45f78f0bc593/ol-17-02-1695-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/1ca836010437/ol-17-02-1695-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/6de3312d9fbb/ol-17-02-1695-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/b9c1702169e2/ol-17-02-1695-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/16fe54b08042/ol-17-02-1695-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/0538342a16b8/ol-17-02-1695-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/112c274f832e/ol-17-02-1695-g08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/061701fdbd28/ol-17-02-1695-g09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/59fccd9b4400/ol-17-02-1695-g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/ec439a0d33cb/ol-17-02-1695-g11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/8c317c7b5830/ol-17-02-1695-g12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/5a49a924c363/ol-17-02-1695-g13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/d74284a6c1ec/ol-17-02-1695-g14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/586854b775aa/ol-17-02-1695-g15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/4cbf665527d9/ol-17-02-1695-g16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/6befa44d5def/ol-17-02-1695-g17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76b3/6341845/d5fb6a3e04ef/ol-17-02-1695-g18.jpg

相似文献

1
Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.微小RNA-15b-5p在肝细胞癌中的致癌价值及生物信息学研究
Oncol Lett. 2019 Feb;17(2):1695-1713. doi: 10.3892/ol.2018.9748. Epub 2018 Nov 22.
2
Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.miR-122-5p在肝细胞癌中的潜在临床价值及假定生物学功能:一项使用微阵列和RNA测序数据的综合研究
Oncol Lett. 2018 Dec;16(6):6918-6929. doi: 10.3892/ol.2018.9523. Epub 2018 Sep 28.
3
Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.微小RNA-196b-5p在肝细胞癌中的临床意义及其潜在分子机制
J Cancer. 2019 Aug 29;10(22):5355-5370. doi: 10.7150/jca.29293. eCollection 2019.
4
Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation.miR-21-5p在肝细胞癌中的临床意义及分子机制研究:基于24项研究的系统评价和生物信息学研究
Oncol Lett. 2019 Jan;17(1):230-246. doi: 10.3892/ol.2018.9627. Epub 2018 Oct 26.
5
Clinical value and potential targets of miR-224-5p in hepatocellular carcinoma validated by a TCGA- and GEO- based study.基于TCGA和GEO研究验证miR-224-5p在肝细胞癌中的临床价值及潜在靶点
Int J Clin Exp Pathol. 2017 Sep 1;10(9):9970-9989. eCollection 2017.
6
Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.基于 RT-qPCR 和计算机分析评估 miR-302b-5p 在肝癌中的表达及其分子机制。
Pathol Res Pract. 2019 Jul;215(7):152424. doi: 10.1016/j.prp.2019.04.016. Epub 2019 Apr 29.
7
Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.肝细胞癌中miR-26a-5p的下调:一项qRT-PCR和生物信息学研究。
Pathol Res Pract. 2017 Dec;213(12):1494-1509. doi: 10.1016/j.prp.2017.10.001. Epub 2017 Oct 10.
8
Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.miR-452-5p在前列腺癌肿瘤发生中的作用:一项基于癌症基因组图谱(TCGA)、基因表达综合数据库(GEO)及生物信息学分析的研究
Pathol Res Pract. 2018 May;214(5):732-749. doi: 10.1016/j.prp.2018.03.002. Epub 2018 Mar 6.
9
Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.链特异性miRNA-101-3p和miRNA-101-5p对肝细胞癌的诊断价值及其可能作用机制的生物信息学分析
FEBS Open Bio. 2017 Dec 20;8(1):64-84. doi: 10.1002/2211-5463.12349. eCollection 2018 Jan.
10
Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.采用微阵列和 RT-qPCR 评估 miR-198-5p 在肺鳞癌中的临床价值。
World J Surg Oncol. 2018 Feb 2;16(1):22. doi: 10.1186/s12957-018-1320-y.

引用本文的文献

1
Expression of miR-15b-5p and toll-like receptor4 as potential novel diagnostic biomarkers for hepatitis C virus-induced hepatocellular carcinoma.miR-15b-5p和Toll样受体4作为丙型肝炎病毒诱导的肝细胞癌潜在新型诊断生物标志物的表达
Noncoding RNA Res. 2024 Dec 15;10:262-268. doi: 10.1016/j.ncrna.2024.12.003. eCollection 2025 Feb.
2
GSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer.GSK3β 和 UCHL3 通过去泛素化来调控 RIPK4 的稳态,从而增强卵巢癌的肿瘤转移。
Oncogene. 2024 Jun;43(25):1885-1899. doi: 10.1038/s41388-024-03040-1. Epub 2024 Apr 25.
3
A Comprehensive Review on Function of miR-15b-5p in Malignant and Non-Malignant Disorders.

本文引用的文献

1
Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics.利用基因芯片和生物信息学对肝细胞癌中长链非编码RNA PVT1基因相互作用调控网络进行综合分析。
Am J Transl Res. 2017 Sep 15;9(9):3904-3917. eCollection 2017.
2
NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.神经介素 N 通过 BDKRB2 和 MAPK/ERK 通路促进肝细胞癌进展。
Oncotarget. 2017 Feb 14;8(7):12174-12185. doi: 10.18632/oncotarget.14556.
3
Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.
miR-15b-5p在恶性和非恶性疾病中的功能综述
Front Oncol. 2022 May 2;12:870996. doi: 10.3389/fonc.2022.870996. eCollection 2022.
4
Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis.用萝卜硫素和靶向 miR-15b-5p 的肽核酸(PNA)处理人类神经胶质瘤 U251 细胞:诱导细胞凋亡的协同作用。
Molecules. 2022 Feb 15;27(4):1299. doi: 10.3390/molecules27041299.
5
RHO GTPase-Related Long Noncoding RNAs in Human Cancers.人类癌症中与RHO GTP酶相关的长链非编码RNA
Cancers (Basel). 2021 Oct 27;13(21):5386. doi: 10.3390/cancers13215386.
6
Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma.miR-889的表达增强预示着肝细胞癌预后不良并促进细胞进展。
Diagn Pathol. 2021 Jun 11;16(1):51. doi: 10.1186/s13000-021-01111-5.
7
miR-15b, a diagnostic biomarker and therapeutic target, inhibits oesophageal cancer progression by regulating the PI3K/AKT signalling pathway.微小RNA-15b作为一种诊断生物标志物和治疗靶点,通过调节PI3K/AKT信号通路抑制食管癌进展。
Exp Ther Med. 2020 Dec;20(6):222. doi: 10.3892/etm.2020.9352. Epub 2020 Oct 15.
8
MicroRNA‑15b‑5p exerts its tumor repressive role via targeting GDI2: A novel insight into the pathogenesis of thyroid carcinoma.微小 RNA-15b-5p 通过靶向 GDI2 发挥其肿瘤抑制作用:甲状腺癌发病机制的新见解。
Mol Med Rep. 2020 Oct;22(4):2723-2732. doi: 10.3892/mmr.2020.11343. Epub 2020 Jul 15.
9
LNC473 Regulating APAF1 IRES-Dependent Translation via Competitive Sponging miR574 and miR15b: Implications in Colorectal Cancer.LNC473通过竞争性结合miR574和miR15b调控APAF1内部核糖体进入位点依赖性翻译:对结直肠癌的影响
Mol Ther Nucleic Acids. 2020 Sep 4;21:764-779. doi: 10.1016/j.omtn.2020.07.009. Epub 2020 Jul 10.
10
Identifying specific miRNAs and associated mRNAs in CD44 and CD90 cancer stem cell subtypes in gastric cancer cell line SNU-5.在胃癌细胞系SNU-5的CD44和CD90癌症干细胞亚型中鉴定特定的微小RNA(miRNA)和相关的信使核糖核酸(mRNA)。
Int J Clin Exp Pathol. 2020 Jun 1;13(6):1313-1323. eCollection 2020.
非小细胞肺癌细胞中长链非编码RNA HOXA11-AS基因相互作用调控网络的综合分析
Cancer Cell Int. 2016 Dec 1;16:89. doi: 10.1186/s12935-016-0366-6. eCollection 2016.
4
SNORD126 promotes HCC and CRC cell growth by activating the PI3K-AKT pathway through FGFR2.SNORD126 通过激活 FGFR2 促进 HCC 和 CRC 细胞生长,从而激活 PI3K-AKT 通路。
J Mol Cell Biol. 2017 Jun 1;9(3):243-255. doi: 10.1093/jmcb/mjw048.
5
C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.C2-神经酰胺通过 PI3K/AKT/mTOR 和 Erk 信号通路增强索拉非尼诱导的 HCC 细胞中的 caspase 依赖性细胞凋亡。
Appl Microbiol Biotechnol. 2017 Feb;101(4):1535-1546. doi: 10.1007/s00253-016-7930-9. Epub 2016 Nov 2.
6
Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study.TRAF6与肝癌恶化的关系:一项免疫组织化学和体外研究。
Cancer Cell Int. 2016 Sep 29;16:76. doi: 10.1186/s12935-016-0352-z. eCollection 2016.
7
Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma.微小RNA-132的下调表明肝细胞癌病情进展。
Exp Ther Med. 2016 Oct;12(4):2095-2101. doi: 10.3892/etm.2016.3613. Epub 2016 Aug 23.
8
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.IGF2 通过表观遗传机制在肝细胞癌中上调,并且是实验模型中可操作的癌基因产物。
Gastroenterology. 2016 Dec;151(6):1192-1205. doi: 10.1053/j.gastro.2016.09.001. Epub 2016 Sep 7.
9
Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study.肝细胞癌中低表达的miR-198及其潜在靶点:一项临床病理和计算机模拟研究
Onco Targets Ther. 2016 Aug 22;9:5163-80. doi: 10.2147/OTT.S108828. eCollection 2016.
10
An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps.肝细胞癌基因特征的封装、微小RNA-132预测的靶基因及相应重叠部分
PLoS One. 2016 Jul 28;11(7):e0159498. doi: 10.1371/journal.pone.0159498. eCollection 2016.